NeuroPace Announces Preliminary Unaudited Fourth Quarter and Full-Year 2021 Revenue
11 janv. 2022 16h03 HE
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from...
NeuroPace to Present at 40th Annual J.P. Morgan Healthcare Conference
16 déc. 2021 07h00 HE
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif., Dec. 16, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from...
NeuroPace Reports Third Quarter 2021 Financial Results
10 nov. 2021 16h03 HE
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from...
NeuroPace Receives IDE Approval to Initiate NAUTILUS Pivotal Study of its RNS System for Idiopathic Generalized Epilepsy
10 nov. 2021 16h02 HE
|
NeuroPace, Inc.
IDE study will be first to evaluate the effectiveness of brain-responsive neuromodulation to treat primary generalized epilepsy in patients aged 12 and older MOUNTAIN VIEW, Calif., Nov. 10, 2021 ...
NeuroPace to Report Third Quarter 2021 Financial Results on November 10, 2021
20 oct. 2021 16h05 HE
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif., Oct. 20, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from...
NeuroPace Announces Addition of Lisa Andrade to the Board
19 oct. 2021 16h03 HE
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc., (Nasdaq:NPCE) a medical technology company dedicated to transforming the lives of people suffering from epilepsy, today...
NeuroPace to Participate in Upcoming Conferences
23 août 2021 16h03 HE
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif., Aug. 23, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from...
NeuroPace Reports Second Quarter 2021 Financial Results
12 août 2021 16h03 HE
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif. , Aug. 12, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from...
NeuroPace To Report Second Quarter 2021 Financial Results on August 12, 2021
22 juil. 2021 16h03 HE
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif., July 22, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from...
NeuroPace Awarded Five-Year NIH Grant Funding of More than $9M to Study RNS System in Patients with Lennox-Gastaut Syndrome
30 juin 2021 08h00 HE
|
NeuroPace, Inc.
Feasibility IDE study will be the first to evaluate responsive neuromodulation for a severe and disabling childhood-onset epilepsy MOUNTAIN VIEW, Calif., June 30, 2021 (GLOBE NEWSWIRE) --...